एलएमसी का वर्चुअल मधुमेह रोकथाम अध्ययन अपने अंतिम प्रतिभागियों के नामांकन की तैयारी में है

In 2019, LMC Healthcare with funding by the Public Health Agency of Canada, began enrolling Canadian’s in a first in Canada research study. Named the Canadian Diabetes Prevention Program (CDPP), the study is supported by multiple partner organization including Diabetes Canada and INTERVENT International. The study offers a lifestyle change program, delivered online and over the phone, to help Canadians reduce their risk of developing type 2 diabetes. The CDPP is based on a similar study developed by the Centers for Disease Control and Prevention (CDC) in the United States that demonstrated success in reducing future risk of type 2 diabetes.

After enrolling participants for 2 years, we are preparing to enrol our final participants before this spring. Our final participants will continue to participate for 12 months, after which we will be preparing a research paper and publishing our findings. The program is continuing to enrol 200 more participants before spring 2022. Click the button for more information CDPP Info